Drugs, China & AI

Check out the accompanying pdf and chart collection. Executive Summary: The S&P 500 sector with the brightest 2024 earnings growth outlook is none other than Health Care, with a share price index that’s a deep underperformer this year, Jackie reports. One of its component industries accounts for much of both this year’s stock price pain and next year’s projected earnings gains—pharmaceuticals. Three drug makers in particular appear bound for standout earnings next year. … Also: China’s government is not doing what it takes to overcome its formidable economic challenges. … And in today’s Disruptive Technologies segment: one tech veteran’s advice for working with AI, warts and all.